Performance of 18F-fluciclovine PET/MR in the evaluation of osseous metastases from castration-resistant prostate cancer.
Bárbara Juarez AmorimVinay PrabhuSara S MarcoDebra GervaisWilliam E PalmerPedram HeidariMark VangelPhilip J SaylorOnofrio Antonio CatalanoPublished in: European journal of nuclear medicine and molecular imaging (2019)
This study suggests that fluciclovine-PET/MR and MR have high sensitivity for detecting osseous metastases in CRPC. Fluciclovine-PET alone underperformed in detecting late sclerotic lesions. The inverse correlation between SUVmax and ADCmean suggests a possible relationship between tumor metabolism and cellularity.